FDA regulation and approval of medical devices: 1976-2020

3 August 2021 - US law generally requires testing of high-risk medical devices prior to approval, as well as pre-market evaluation ...

Read more →

FDA grants breakthrough device designation status for Hancock Jaffe's VenoValve

3 August 2021 - VenoValve is a potential treatment for approximately 2.4 million U.S. patients that suffer from severe chronic venous ...

Read more →

Biofourmis earns FDA's first ever breakthrough device designation for a novel digital therapeutic for heart failure

29 July 2021 - BiovitalsHF approved for expedited FDA review process as a first-in-class digital therapeutic for heart failure that augments ...

Read more →

Evren Technologies receives FDA breakthrough device designation for the Phoenix

21 July 2021 - Evren Technologies announced today that its non-invasive Phoenix earbud device received Breakthrough Device Designation from the ...

Read more →

NeuroMetrix receives FDA breakthrough device designation for treatment of fibromyalgia with its wearable neurostimulation technology

20 July 2021 - NeuroMetrix today announced that its Quell device has received breakthrough designation from the U.S. FDA for treating ...

Read more →

Nevro announces FDA approval of its 10 kHz high frequency spinal cord stimulation therapy for treatment of chronic pain associated with painful diabetic neuropathy

19 July 2021 - HFX for painful diabetic neuropathy now the only spinal cord stimulation system approved by FDA to treat ...

Read more →

Endologix receives FDA breakthrough device designation for ChEVAS system

19 July 2021 - Investigational EVAS system designed for patients with complex abdominal aortic aneurysm. ...

Read more →

Stryker announces the FDA clearance of the first biodegradable subacromial balloon spacer, filling a gap in the shoulder continuum of care

13 July 2021 - The InSpace balloon implant is a breakthrough solution for arthroscopic treatment of massive irreparable rotator cuff tears ...

Read more →

Hyalex Orthopaedics receives FDA breakthrough device designation for novel Hyalex cartilage system

7 July 2021 - Hyalex Orthopaedics announced that the Hyalex Cartilage System has been granted breakthrough device designation from the U.S. ...

Read more →

Neuroelectrics granted FDA breakthrough device designation for new therapeutic neuromodulation platform to treat refractory focal epilepsy

30 June 2021 - In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44% median ...

Read more →

Neuros Medical receives FDA breakthrough device designation for its novel Altius high frequency nerve block system

29 June 2021 - Neuros Medical announced today that it has received Breakthrough Device Designation from the U.S. FDA for the ...

Read more →

Medtronic receives FDA expanded approval for Arctic Front family of cardiac cryoablation catheters for initial use for recurrent symptomatic paroxysmal atrial fibrillation

21 June 2021 - First and only approval to indicate cryoablation as an initial rhythm control strategy. ...

Read more →

Sensome receives FDA breakthrough device designation for its AI powered stroke guidewire

21 June 2021 - Sensome announced today that it has been granted a Breakthrough Device designation by the Center of Devices ...

Read more →

The FDA grants a breakthrough device designation to the MIScoli, an innovative vertebral body tethering device to treat idiopathic scoliosis

18 June 2021 - Spinologics announced today that the U.S. FDA has granted the company a breakthrough device designation for its ...

Read more →

3D bioprinting can help end organ transplant waitlists — if the FDA stops delaying

18 June 2021 - Right now, more than 100,000 Americans are waiting for organ transplants. Due to a lack of ...

Read more →